Navigation Links
ARIUS to Present at American Association for Cancer Research Annual,Meeting

- Lead Programs CD44 and Trop-2 poster Presentations Reveal New Findings -

TORONTO, April 4 - ARIUS Research Inc. (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that new information on the preclinical activity of two of its novel monoclonal antibodies will be presented at the Annual Meeting of the American Association for Cancer Research (AACR), which runs from April 14-18, 2007 in Los Angeles, California. The first poster presentation will outline the activity of ARIUS' lead anti-CD44 antibody, ARH460-16-2, against liver cancer, a significant market in Asia and a growing concern in North America.

CD44 is an important marker for cancer stem cells that often survive treatment and keep growing to spread tumors. Studies of patients with different types of cancer have shown that CD44 can be linked to poorer chances of survival. ARIUS anti-CD44 antibodies have previously been found to control tumor growth and improve survival in breast and prostate cancer models.

The second poster will describe the activity of two antibodies targeting Trop-2 in a variety of solid tumors including breast and colon cancers plus pancreatic cancer, an area without effective treatment options. Trop-2 is a new target for drugs in cancer. Recently, increasing Trop-2 has been shown to
stimulate tumor growth. Studies in colon cancer patients found it is also associated with more aggressive disease and cancer death.

"Presenting our most recent findings for two of our lead programs, CD44 and Trop-2, is an excellent opportunity to showcase the potential of our products as we look for partners," said Dr. David Young, President and CEO. "Moreover, this important preclinical work also highlights the value and capabilities of our FunctionFIRST(TM) platform to generate novel antibodies with promising anti-cancer properties."

Novel antibody ARH460-16-2 rec
'"/>




Page: 1 2 3 4

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:10/30/2014)... 30, 2014  The number of retail health clinics ... growing steadily, thanks to drug store chains, according to ... the economic downturn, retail clinic growth had been at ... as the number of retail clinics reached nearly 1,600 ... Clinics Market Overview and 2014 Consumer Survey Results .  ...
(Date:10/30/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will ... September 30, 2014 on Thursday, November 6, 2014, after ... , president and chief executive officer, will host a ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... Webcast of the conference call can be accessed through ...
(Date:10/30/2014)... 2014 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China , ... quarter 2014 financial results on Wednesday, November 5, 2014 ... management will hold a conference call at 7:30 a.m. ... 8:30 p.m., Beijing Time on November 6, 2014, to ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2China Biologic to Report Third Quarter 2014 Financial Results 2
... Denmark and SEATTLE, May 2, 2011 CMC ... operations in Copenhagen, Denmark and Seattle, Washington USA, ... to serve at its Chief Executive Officer. CMC ... to delivering  world class, fully integrated, biopharmaceutical process ...
... Anticipating record attendance among the investment community at the ... 10-11 at the Marriott Resort in Ypsilanti, Mich., event organizers ... for funding at this year,s event. The 41 presenting ... were selected from a competitive pool of 85 applications.  During ...
Cached Medicine Technology:CMC Biologics Announces Appointment of New CEO 2Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event 2Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event 3
(Date:10/30/2014)... and her research group at the DFG Research Center ... the TU Dresden (CRTD) demonstrated for the first time ... cord in three dimensions from mouse embryonic stem cells. ... interneurons along the dorsal/ventral axis was observed., This study ... " Stem Cell Reports " on 30.10.2014 ., For ...
(Date:10/30/2014)... Florida (PRWEB) October 30, 2014 Timothy, ... visit to Pompano Beach firefighters, showing that you are ... , Timothy met firefighters Tracey and Carl at ... Galuppi’s Restaurant and the Pompano Beach Chamber of Commerce. ... the fire truck, letting Timothy wear his real fireman’s ...
(Date:10/30/2014)... Diego, Calif. (PRWEB) October 30, 2014 ... longer mutually exclusive concepts in the medical-grade skin ... on the development of uniquely potent topical dermatological ... Health System ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 ... available glycolic acid concentrations (50% and 70%) and ...
(Date:10/30/2014)... Paramount Rx, a full-service prescription benefits ... to help people save money through its innovative discount ... prescription drugs in the new health care system, the ... bridge the relationship between consumers, businesses and the pharmacy ... people face today with medical costs is the rising ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3
... law firm files notice of claim against City of New York ... ... NY (Lexis Nexis) August 28, 2008 -- http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc ... Sanders, Sanders, Block, Woycik, Viener & Grossman, P.C. in Bronx, New ...
... Efforts to Create Sensible Fire Safety ... Legislation, ... voted to maintain California,s tough fire,standards by striking down proposed fire retardant ... sensible,legislation to address fire safety regulations in the state. The bill would,have ...
... gain access to innovative medical, education and news ... radio channel created for medical professionals by medical ... 157 announced today a new,strategic programming partnership with ... and largest, independent,association for physicians-in-training., Gary Epstein, ...
... American Society for Therapeutic Radiology and Oncology has selected ... honorary member. Dr. Evans will be recognized during the ... during ASTRO,s 50th Annual Meeting in Boston., Dr. Evans ... study of childhood cancer for decades. She was one ...
... cuts risk in half, study finds , , WEDNESDAY, Aug. 27 ... of preterm delivery, cut the rate of cerebral palsy in ... "If deemed to be at high or immediate risk of ... consider using magnesium sulfate to prevent their child from having ...
... treating ,wet, form of the eye disease , , WEDNESDAY, ... States and China have identified the first gene directly ... one of two forms of age-related macular degeneration that ... older Americans. , The discovery, based on work with ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:California Senate Rejects Proposed Effort to Weaken Fire Safety Standards 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Magnesium Sulfate Reduces Threat of Cerebral Palsy 2Health News:Magnesium Sulfate Reduces Threat of Cerebral Palsy 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3
... 45° Prism is designed ... and are recommended for ... BRVO etc.) and Rhegmatogenus ... be used for panretinal ...
The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,...
... patented ACS lenses offer the high resolution, ... the original clariVits. The simple two part ... its integrity during surgery. Simply autoclave, add ... then lock together for use. (ACS) AutoClave ...
... With somewhat higher magnification and ... is best suited for detailed ... The Central Retinal is ideal ... in membrane peeling in proliferative ...
Medicine Products: